6-IODO-8-PHENYLIMIDAZO[1,2-A]PYRAZINE, 95%, 250mg

1-(PYRIDIN-4-YLMETHYL)-1,4-DIAZEPANE HCL, 95.0%, 2g

2-Methylsulfonyl-4-trifluoromethylbenzoic acid, 95.0%, 1g

3-Bromopyrazolo[1,5-a]pyridin-2-ol, 95.0%, 1g

2-Cyano-N-(pyridin-3-yl)acetamide, 97%, 1g

2-Bromo-3,4,5-trimethoxy-benzaldehyde, 95%, 10g

N-(3-Boc-aminomethylphenyl)-N-(4-methoxyphenyl)amine, 97.0%, 1g

4'-bromo-3-(1,3-dioxolan-2-yl)benzophenone, 97.0%, 1g

4-Bromo-2-(trifluoromethoxy)benzonitrile, 95.0%, 25g

2-Bromo-4-iodopyridine, 97.0%, 5g

Diethyl P-[(2-amino-4-thiazolyl)methyl]phosphonate, 250mg

Plan PLPH S100x/1.25 phase contrast objective

2-hydroxy-2,2-diphenylacetohydrazide, 10g